We invite you to join Indian Country ECHO for a General Session on Metabolic Health in Indian Country: Food as Medicine, GLP-1 Therapies, Clinical Outcomes, and Access. In this presentation, Dr. Danica Love Brown, Dr. Nicholas Duca, and Dr. Hannah Wenger compare obesity and metabolic-disease burdens among American Indian and Alaska Native populations and the broader US, recognizing variation across communities and regions. Then, faculty review GLP-1 and dual GIP/GLP-1 pharmacology, established benefits, safety considerations, and common misconceptions, explain how food as medicine, locally relevant traditional foods, and food sovereignty can complement pharmacologic and other metabolic care and identify emerging applications of GLP-1 and dual GIP/GLP-1 medications involving substance use disorders, liver disease, inflammation, pain, function, and quality of life. Finally, they describe practical differences in medication access and continuity across commercial insurance, Medicare, Medicaid, IHS, and Tribal health programs. CE will be available.

To join, simply click here at the time of the General Session (October 27th at 12pm PT): https://echo.zoom.us/j/99475693462?pwd=NGlaMjBrNHZkclBOSXRySHNHMzB4Zz09

Speakers: Danica Love Brown, PhD, MSW, CACIII | Consultant, White Crane Consultation, LLC; Nicholas S. Duca, MD | Associate Professor of Medicine, Penn State College of Medicine; General Internist, Penn State Health Milton S. Hershey Medical Center; Hannah Wenger, MD | Associate Physician, Division of General Internal Medicine, Massachusetts General Hospital; Instructor in Medicine, Harvard Medical School; Partner, The Raven Collective;